Argan (AGX) Cash Flow Statement

Click line-items for a historical chart and %

Net income
Removal of (income) loss on discontinued operations
Income from continuing operations
Stock compensation expense	1.77M
Deferred income tax expense	-1.69M
Amortization of purchased intangibles	752K
Depreciation	1.44M
Other	-119K
Restricted cash
Accounts receivable	21.3M
Costs and estimated earnings in excess of billings
Prepaid expenses and other assets	-1.43M
Accounts payable and accrued expenses	50.1M
Billings in excess of costs and estimated earnings	54.56M
Net cash provided by continuing operating activities
Net cash (used in) provided by discontinued operating activities
Net cash provided by operating activities	185.31M
Purchases of property and equipment, net	-2.48M
Net cash provided by investing activities of discontinued operations
Net cash provided by (used in) investing activities	-163.48M
Proceeds from stock options exercised	10.99M
Proceeds from warrants exercised
Principal payments on long-term debt
Net cash provided by (used in) financing activities	-11.77M
NET INCREASE IN CASH AND CASH EQUIVALENTS	9.87M
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	160.91M
CASH AND CASH EQUIVALENTS, END OF PERIOD	170.78M
Income taxes	26.36M
Interest

Entities mentioned with AGX

View All Entities